Direct-acting antivirals for chronic hepatitis C
作者： Janus C Jakobsen , Emil Eik Nielsen , Joshua Feinberg , Kiran Kumar Katakam , Kristina Fobian
DOI: 10.1002/14651858.CD012143.PUB3
关键词:
摘要: … chronic hepatitis C, the majority of whom had not been treated previously. Rates of hepatitis … or harmful effects on other clinical outcomes for chronic HCV. DAAs may reduce the number …
irb.hr
regsj.dk参考文章(379)
Robert A Ogert, John A Howe, John M Vierling, Paul Y Kwo, Eric J Lawitz, Jonathan McCone, Eugene R Schiff, David Pound, Mitchell N Davis, Stuart C Gordon, Natarajan Ravendhran, Lorenzo Rossaro, Ira M Jacobson, Robert Ralston, Eirum Chaudhri, Ping Qiu, Lisa D Pedicone, Clifford A Brass, Janice K Albrecht, Richard JO Barnard, Daria J Hazuda, Anita YM Howe, Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial. Antiviral Therapy. ,vol. 18, pp. 387- 397 ,(2013) , 10.3851/IMP2549
Adrian M. Di Bisceglie, Geoffrey M. Dusheiko, Andrew J. Muir, Stefan Zeuzem, Patrick Marcellin, Natalie H. Bzowej, Ira M. Jacobson, Nathalie Adda, Leif Bengtsson, Robert S. Kauffman, Shelley George, Rajender Reddy, Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin: Analyses of Pre-Defined Subpopulations in the Phase 3 Advance Trial Gastroenterology. ,vol. 140, pp. S- 908 ,(2011) , 10.1016/S0016-5085(11)63770-0
Jean-Pierre Bronowicki, Stanislas Pol, Paul J Thuluvath, Dominique Larrey, Claudia T Martorell, Vinod K Rustgi, David W Morris, Ziad Younes, Michael W Fried, Marc Bourlière, Christophe Hézode, K Rajender Reddy, Omar Massoud, Gary A Abrams, Vlad Ratziu, Bing He, Timothy Eley, Alaa Ahmad, David Cohen, Robert Hindes, Fiona McPhee, Bridget Reilly, Patricia Mendez, Eric Hughes, Randomized study of asunaprevir plus pegylated interferon-α and ribavirin for previously untreated genotype 1 chronic hepatitis C. Antiviral Therapy. ,vol. 18, pp. 885- 893 ,(2013) , 10.3851/IMP2660
Shannon A. Ferrante, Jagpreet Chhatwal, Erik J. Dasbach, Vilma Sniukiene, Fred Poordad, Jean-Pierre Bronowicki, Antoine El Khoury, Clifford A. Brass, Projecting the Clinical Impact of Therapeutic Regimens Including Boceprevir in Previously Untreated Adult Subjects With Chronic Hepatitis C Genotype 1 Gastroenterology. ,vol. 140, pp. S- 909 ,(2011) , 10.1016/S0016-5085(11)63772-4
Eric Lawitz, Xavier Forns, Stefan Zeuzem, Edward Gane, Jean-Pierre Bronowicki, Pietro Andreone, Andrzej Horban, Ashley Brown, Monika Peeters, Oliver Lenz, Sivi Ouwerkerk-Mahadevan, Ronald Kalmeijer, Maria Beumont-Mauviel, 869b Simeprevir (TMC435) With Peginterferon/Ribavirin for Treatment of Chronic HCV Genotype 1 Infection in Patients Who Relapsed After Previous Interferon-Based Therapy: Results From PROMISE, a Phase III Trial Gastroenterology. ,vol. 144, ,(2013) , 10.1016/S0016-5085(13)60542-9
S. Zeuzem, R. Ghalib, K.R. Reddy, P.J. Pockros, Z.B. Ari, Y. Zhao, D. Brown, M. DiNubile, M. Robertson, J. Wahl, E. Barr, J. Butterton, G07 : The phase 3 C-EDGE treatment-naïve (TN) study of a 12-week oral regimen of grazoprevir (GZR, MK-5172)/ elbasvir (EBR, MK-8742) in patients with chronic HCV genotype (GT) 1, 4, or 6 infection Journal of Hepatology. ,vol. 62, ,(2015) , 10.1016/S0168-8278(15)30056-8
Fatih Ermis, New treatment strategies for hepatitis C infection. World Journal of Hepatology. ,vol. 7, pp. 2100- 2109 ,(2015) , 10.4254/WJH.V7.I17.2100
Gregory J. Dore, Brian Conway, Yan Luo, Ewa Janczewska, Brygida Knysz, Yan Liu, Adrian Streinu-Cercel, Florin Alexandru Caruntu, Manuela Curescu, Richard Skoien, Wayne Ghesquiere, Włodzimierz Mazur, Alejandro Soza, Francisco Fuster, Susan Greenbloom, Adriana Motoc, Victoria Arama, David Shaw, Istvan Tornai, Joseph Sasadeusz, Olav Dalgard, Danielle Sullivan, Xuan Liu, Mudra Kapoor, Andrew Campbell, Thomas Podsadecki, Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials Journal of Hepatology. ,vol. 64, pp. 19- 28 ,(2016) , 10.1016/J.JHEP.2015.08.015
Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud, Lise Lotte Gluud, None, Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C. Cochrane Database of Systematic Reviews. ,vol. 2014, ,(2014) , 10.1002/14651858.CD005441.PUB3
Jesper Brok, Lise Lotte Gluud, Christian Gluud, Ribavirin plus interferon versus interferon for chronic hepatitis C. Cochrane Database of Systematic Reviews. ,(2010) , 10.1002/14651858.CD005445.PUB2